Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Drug Dev Res. 2011 Dec;72(8):756–763. doi: 10.1002/ddr.20484

Table 2.

Medications taken by the patients with RA (N = 108)

Variable Total sample (n = 108) Adherent group (n = 98) Non-adherent group (n = 10) p value
Methotrexate 76 (70%) 70 (71%) 6 (60%) 0.34
Prednisone 41 (38%) 36 (37%) 5 (50%) 0.50
Hydroxychloroquine 31 (29%) 29 (30%) 2 (20%)
Sulfasalazine 16 (15%) 13 (13%) 4 (40%)
Etanercept 12 (11%) 9 (9%) 3 (30%)
Adalimumab 11 (10%) 10 (10%) 1 (10%)
Abatacept 6 (6%) 5 (5%) 1 (10%)
Infliximab 5 (5%) 5 (5%) 0
Leflunomide 4 (4%) 4 (4%) 0
Rituximab 1 (1%) 1 (1%) 0
Cytoxan 1 (1%) 1 (1%) 0

Proportions if adherent and nonadherent groups were compared with Chi square analyses.

Chi square analyses were not performed when there were less than 5 cases per cell.

Totals may be equal 100% due to rounding.